Pacemaker market is anticipated to grow at a CAGR of over 9.2 % from 2014 to 2025

Posted on

A pacemaker is a small, electrically charged device which is implanted under the skin to help manage arrhythmias or irregular heartbeats. A pacemaker is required if a person’s heart is beating too slow or too fast. In any case, the body does not get adequate blood supply. This can result in shortness of breath, fatigue, damage to vital organs, lightheadedness or fainting, and eventual death. A pacemaker controls the electrical system of the heart that manages heart rhythms.

The global pacemaker market is anticipated to grow at a CAGR of over 9.2 % from 2014 to 2025, as per a new report published by Grand View Research Inc. This growth is attributed to the factors such as growing prevalence of cardiovascular conditions (heart diseases) and the availability of medical coverage.

Medtronic PLC recently launched the world’s smallest pacemaker called Micra Transcatheter Pacing System (TPS). This device provides the highly developed pacing technology and is as big as a large vitamin capsule! The Micra TPS was intended especially for patients who need more than one heart devices. The device has an exclusive feature that allows it to be permanently turned off. This enables the device to remain in the body while a new device can be implanted without any risks of electrical interaction. Approved by the United States Food & Drug Administration (FDA), TPS is the only leadless device accepted for use.

This device can be carried using a catheter and implanted into the heart, providing a safer replacement to the usual pacemakers without any of the leads-related complexities. The major advantage of the device is that it lets automatically set pacing therapy and has a battery that can last for approximately 10 years.

The global pacemaker market is said to reach USD 12.3 billion by 2025. The major factors driving the market growth are growing occurrences of Cardiovascular Diseases (CVDs) and rising awareness levels regarding CVDs and their long-term effects. This is also increasing the popularity of advanced treatment options, which is likely to increase the usage rates of the product. The key companies operating in the global pacemaker market are ZOLL Medical Corp.; MEDICO S.p.A.; Medtronic PLC; Cordis Inc.; and Boston Scientific Corp.

Read more at:
http://www.grandviewresearch.com/industry-analysis/pacemaker-market

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s